Multi-omics dataset to decipher the complexity of drug resistance in diffuse large B-cell lymphoma

The prognosis of patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) remains unsatisfactory and, despite major advances in genomic studies, the biological mechanisms underlying chemoresistance are still poorly understood. We conducted for the first time a large-scale differ...

Descripción completa

Detalles Bibliográficos
Autores principales: Fornecker, Luc-Matthieu, Muller, Leslie, Bertrand, Frédéric, Paul, Nicodème, Pichot, Angélique, Herbrecht, Raoul, Chenard, Marie-Pierre, Mauvieux, Laurent, Vallat, Laurent, Bahram, Seiamak, Cianférani, Sarah, Carapito, Raphaël, Carapito, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351558/
https://www.ncbi.nlm.nih.gov/pubmed/30696890
http://dx.doi.org/10.1038/s41598-018-37273-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351558/
https://www.ncbi.nlm.nih.gov/pubmed/30696890
http://dx.doi.org/10.1038/s41598-018-37273-4

Ejemplares similares